Baraclude
Baraclude

5.74
For patients managing viral infections, this generic medicine inhibits the reverse transcriptase enzyme. Disrupts viral replication to address underlying infection markers and systemic load.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Entecavir
Reference Brand
Entecavir
Product Origin
Generic Alternative
Reference Manufacturer
Bristol-Myers Squibb
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antivirals, Hepatitis Treatment
Product Category
Nucleoside Analog Reverse Transcriptase Inhibitor
Pharmacological Class
Hepatitis B Antiviral
Manufacturer Description
Intended to relieve chronic viral replication in the liver to support hepatic wellness and target viral DNA polymerase.
Mechanism of Action
Competes with deoxyguanosine triphosphate to block vital functions of HBV polymerase, stopping viral chain elongation.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Hypersensitivity to entecavir
Severe Adverse Events
Lactic acidosis — requires immediate medical attention, Severe exacerbation of hepatitis B — requires immediate medical attention
Common Side Effects
Headache, Fatigue, Dizziness
Uncommon Side Effects
Nausea, Elevated liver enzymes, Dyspepsia
Drug Interactions
Ganciclovir, Tenofovir
Pregnancy Safety Warnings
TGA Category C: Limited clinical data. Breastfeeding: Avoid.
Age Restrictions
Approved for patients over two years of age.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Baraclude is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to access Antibiotic Tablets AU - Buy Doxycycline AU